Funding profile · Health benefits (ICHRA)
Thatch
About $192.5 million in equity announced across four financings, a $1 billion valuation in September 2026 set by existing investors, data vendors that disagree on the Series C, and no Form D under the company’s name.
Data as of November 11, 2026. Company-reported figures are labeled. Valuations are as announced or as reported by data vendors and are not confirmed by any filing.
Rounds at a glance
| When | Round | Amount | Investors | Source |
|---|---|---|---|---|
| Feb 2023 | Pre-seed and seed | Over $6M total, including a $5.6M seed | Seed co-led by Andreessen Horowitz and GV; Lux Capital, Quiet Capital, Not Boring Capital, BrightEdge | Company release |
| Sep 2024 | Series A | $38M | Led by Index Ventures and General Catalyst; SemperVirens, The General Partnership; Andreessen Horowitz and Avid Ventures returning | Company release |
| Apr 2025 | Series B | $40M at a reported $410M valuation | Led by Index Ventures; Andreessen Horowitz, General Catalyst, SemperVirens, PeopleTech Partners, The General Partnership; ADP Ventures new | Company release |
| Apr 2026 | Venteur customer transition | Terms not disclosed | Employers, employees and brokers served by Venteur moving to Thatch | Company-stated |
| Sep 2026 | Series C | $108M at a $1B post-money valuation | The General Partnership, Index Ventures, General Catalyst, Andreessen Horowitz; ADP Ventures, Paychex, Eli Lilly and Company, Scale Venture Partners, QuantumLight, SemperVirens, Quiet Capital | Company release |
| 2026 | Series C, vendor records | $69.9M at $647.1M (Dealroom); $130M at $1.03B in April (Forge) | Not reconciled with the company’s figures | Conflict |
What the filings show
Thatch Health, Inc. · Form D search · checked Nov 11, 2026
- Result
- No Form D located for any round
- Searched
- EDGAR full-text search of Form D filings for “Thatch Health”, “Thatch” and the founders’ names, plus the EDGAR company index
- Name collision
- The only Form D filer with the name is Thatch Group Fund, LLC (CIK 0002032831), a pooled investment fund based in Orem, Utah, with no overlap in related persons. It is unrelated.
- Implication
- None of the roughly $192.5 million announced appears on the SEC record under this name
Reading the filings
- Four financings and no notice on file.As with several venture-backed health companies, Thatch’s rounds appear in press releases and data vendors but not in EDGAR under its legal name. Raising under Section 4(a)(2), or through an entity with another name, would explain it. The absence is a disclosure gap, not evidence of wrongdoing.
- Three vendors, three different Series C rounds.The company and TechCrunch report $108 million at a $1 billion valuation in September 2026. Dealroom lists $69.9 million at $647.1 million. Forge lists $130 million at $1.03 billion in April. Staged closings or a tranche structure could account for some of the difference. Without a filing, none can be confirmed.
- The insiders set the price.TechCrunch reported that the $108 million came from existing investors, and the company did not name a single lead. Insider rounds signal conviction, but they also mean no new lead tested the $1 billion price.
- The strategic investors are distribution, plus one surprise.ADP joined at the Series B and embedded Thatch in its payroll workflow; Paychex joined at the Series C. Both are payroll channels into small and mid-size employers. Eli Lilly’s participation is unusual for a benefits platform and worth watching.
- The valuation rose about 2.4 times in 17 months.From a reported $410 million at the April 2025 Series B to $1 billion in September 2026. The company says annual recurring revenue grew about seven times over the past year, and it reported 8x year-over-year revenue growth at the Series B.
- The business rides on a regulation.Thatch is built on individual coverage HRAs, a federal arrangement first allowed for plan years beginning in 2020 and now also referred to as CHOICE arrangements. Rule changes in Washington could expand or shrink the market quickly.
Commercial signals
| Signal | Detail | Source type |
|---|---|---|
| Customers | More than 5,000 employers as of September 2026, up from more than 1,000 companies at the April 2025 Series B. | Company-stated |
| Growth | Annual recurring revenue up about seven times over the past year. Revenue not disclosed. Unaudited. | Company-stated |
| Distribution | ICHRA benefits embedded in ADP’s payroll platform (2025); Venteur’s employers, employees and brokers transitioning to Thatch (April 2026). | Company-stated |
| Market | Employers offering ICHRA rose from more than 6,600 in 2025 to more than 12,700 in 2026, per the HRA Council. | Independent |
| Strategy | The chief executive told ION Analytics in October 2026 that Thatch will consider acquisitions as the market consolidates. | Independent |
What to watch
- Acquisitions of smaller ICHRA administrators. Competitors include Take Command, PeopleKeep, Remodel Health and Zorro.
- Federal rule changes to ICHRA or CHOICE arrangements, the single largest swing factor for demand.
- A reconciliation of the Series C figures, or any Form D that settles them.
- What Eli Lilly’s stake turns into commercially.
Related companies
Sources
- Public recordEDGAR full-text search, Form D, “Thatch Health” and “Thatch”; Form D, Thatch Group Fund, LLC, CIK 0002032831
- CompanyThatch launches with funding from a16z and GV
- CompanyThatch announces $38M Series A funding
- CompanyThatch raises $40M Series B led by Index Ventures
- IndependentThatch raises $40M to give employees more control of their health insurance choices
- IndependentHealth benefits platform Thatch reaches $1B valuation as healthcare costs surge
- IndependentLatham & Watkins advises Thatch on US$108 million Series C
- IndependentThatch reports $108M Series C at $1B; Forge’s record disagrees
- IndependentThatch hits $1B valuation with Series C
- IndependentThatch secures $108M, reaches $1B valuation
Compiled from SEC records, company releases and published reports as of November 11, 2026. Form D notices report offerings under Regulation D; companies raising under other exemptions may file none. Healthcare Venture Capital Fund holds no position in Thatch. This page is not an offer to sell or a recommendation to buy any security.
